[Membranoproliferative glomerulonephritis and allied glomerulonephritis: development, treatment and prognosis (author's transl)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage; D003911:Dextrans / Q000008:administration & dosage; D004176:Dipyridamole / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007678:Kidney Glomerulus / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage
D003911:Dextrans; D004176:Dipyridamole; D003520:Cyclophosphamide; D011239:Prednisolone; D014568:Urokinase-Type Plasminogen Activator